Skip to content

Study Details

Testing the Drug Ubrogepant in Adults and Young Adults with Migraine

(IRB#: IRB_00149183)

Migraine is a reoccurring headache that varies in pain and can cause other health issues such as sick to the stomach, and sensitivity to light and sound. The study will test a drug called Ubrogepant to treat people with the disease. The study wants to see if the drug will help people with the disease and is safe. People in this study will be randomly treated with the Ubrogepant or a placebo. The drug and placebo are swallowed as a pill. This placebo does not have the treatment. Participation in the study is about 6-7 months. Medical tests will be done in-person, on the phone, and online such as using a computer during the study to track the health of participants.


  • All genders
  • Under 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Under 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 6 to 17 years old
  • History of migraine
  • Migraines last about 3-72 hours
  • Use of current or past medication of at least 1 pill for migraine
  • Participants use specific birth control

Exclusion Criteria

  • History of other diseases such as heart and brain disease
  • Self-harm or thoughts of suicide
  • Alcohol or drug abuse
  • Pregnant

Will I be paid for my time?


For more information contact:

Carly Straley


IRB#: IRB_00149183

PI: Meghan Candee


Approval Date: 2023-05-17 06:00:00

Study Categories: Brain Health Studies

Specialties: Neurology

Last Updated: 6/8/23